CurrentEndo
Get Weekly

Topic · page 87 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 3,441–3,480 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    Safety, pharmacokinetics and pharmacodynamics of HRS ‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial

    Randomized controlled trial

  2. Diabetes Res Clin Pract

    Inflammageing mediated by cytotoxic lymphocytes is associated with diabetes duration

    Cross-sectional study

  3. Diabetes Obes Metab

    Impact of weight loss and weight gain trajectories on body composition in a population at high risk of type 2 diabetes: A prospective cohort analysis

    Cohort study

  4. Diabetologia

    Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial

    Randomized controlled trial

  5. Diabetes Care

    Low Awareness of Diabetes as a Major Risk Factor for Cardiovascular Disease in Middle- and High-Income Countries

    Cross-sectional study

  6. Cardiovasc Diabetol

    Obesity indices and the risk of total and cardiovascular mortality among people with diabetes: a long-term follow-up study in Taiwan

    Cohort study

  7. Cardiovasc Diabetol

    Olive oil consumption, plasma metabolites, and risk of type 2 diabetes and cardiovascular disease

    Randomized controlled trial

  8. Diabet Med

    Real‐world study of the concomitant use of biphasic insulin aspart 30/70 with GLP‐1 receptor agonist versus first‐generation basal insulin with GLP‐1 receptor agonist in type 2 diabetes

    Cohort study

  9. J Clin Endocrinol Metab

    A Plasma Metabolite Score Related to Psychological Distress and Diabetes Risk: A Nested Case-control Study in US Women

    Case-control study

  10. Endocr Pract

    Stroke Prevention by Antihyperglycemic Drugs in Type 2 Diabetes Mellitus

    Meta-analysis

  11. Diabet Med

    An alternative approach using hs‐CRP levels and age of onset in diagnostics of HNF1A‐MODY

    Diagnostic or prognostic study

  12. BMJ Open Diabetes Res Care

    Effects of the ABCC8 R1420H loss-of-function variant on beta-cell function, diabetes incidence, and retinopathy

    Cohort study

  13. Diabetes Obes Metab

    Effect of sodium‐glucose cotransporter‐2 inhibitors on myocardial infarction incidence: A systematic review and meta‐analysis of randomized controlled trials and cohort studies

    Meta-analysis

  14. Diabetes Obes Metab

    Comparative effectiveness of sodium‐glucose co‐transporter‐2 inhibitors and dipeptidyl peptidase‐4 inhibitors on liver function in patients with type 2 diabetes in Japan: A real‐world data analysis

    Cohort study

  15. Diabetologia

    Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease

    Cohort study

  16. Diabetes Metab

    Metformin treatment is associated with improved survival in diabetic patients hospitalized with acute heart failure: A prospective observational study using the Korean acute heart failure registry data

    Cohort study

  17. Diabetes Metab

    Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV randomized controlled trial

    Secondary analysis

  18. Diabetes Obes Metab

    Alanine to glycine ratio is a novel predictive biomarker for type 2 diabetes mellitus

    Cohort study

  19. Diabetes Obes Metab

    Glycaemic control efficacy of switching from dipeptidyl peptidase‐4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study ( SWITCH‐SEMA 2 study)

    Randomized controlled trial

  20. Diabetes Obes Metab

    Advancing type 2 diabetes therapy with iGlarLixi in older people: Pooled analysis of four randomized controlled trials

    Meta-analysis

  21. Diabetes Obes Metab

    Clinical effectiveness and cost‐impact after 2 years of a ketogenic diet and virtual coaching intervention for patients with diabetes

    Cohort study

  22. Endocr Pract

    Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia

    Research article

  23. Diabetes Res Clin Pract

    Coronary artery disease patients with rs7904519 (TCF7L2) are at a persistent risk of type 2 diabetes

    Research article

  24. Cardiovasc Diabetol

    Effects of diabetes mellitus and glycemic traits on cardiovascular morpho-functional phenotypes

    Research article

  25. Cardiovasc Diabetol

    Effects of exenatide on coronary stent’s endothelialization in subjects with type 2 diabetes: a randomized controlled trial. The Rebuild study

    Randomized controlled trial

  26. J Clin Endocrinol Metab

    Sex Differences in Branched-chain Amino Acid and Tryptophan Metabolism and Pathogenesis of Youth-onset Type 2 Diabetes

    Cross-sectional study

  27. Diabetes Res Clin Pract

    Associations between social determinants of health and diabetes self-care behaviors among insured adult patients

    Cross-sectional study

  28. Diabetes Care

    Ambient Heat and Risk of Serious Hypoglycemia in Older Adults With Diabetes Using Insulin in the U.S. and Taiwan: A Cross-National Case-Crossover Study

    Research article

  29. Diabetes Res Clin Pract

    Institutional experience on the impact of glucagon-like peptide-1 agonists (GLP-1) on glycemic control and weight loss in patients with type 2 diabetes at the Dubai Diabetes Center, United Arab Emirates

    Cohort study

  30. Diabetes Res Clin Pract

    Association of insulin resistance and glycemic measures with major abnormal electrocardiogram in older Chinese: Cross-sectional analysis based on the Guangzhou Biobank Cohort study

    Cross-sectional study

  31. Diabetes Care

    High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors

    Cohort study

  32. Diabetes Care

    Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk

    Cohort study

  33. Cardiovasc Diabetol

    An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease

    Cohort study

  34. Diabetologia

    MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial

    Secondary analysis

  35. Diabetes Care

    Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study

    Cohort study

  36. Diabetologia

    Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas

    Meta-analysis

  37. Diabetes Res Clin Pract

    Phase 3 efficacy and safety trial of proposed liraglutide biosimilar for reduction of glycosylated hemoglobin (HbA1c) in patients with Type 2 diabetes mellitus

    Randomized controlled trial

  38. Lancet Diabetes Endocrinol

    Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

    Secondary analysis

  39. Lancet Diabetes Endocrinol

    Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial

    Secondary analysis

  40. Diabetes Care

    Occurrence of Gastrointestinal Adverse Events Upon GLP-1 Receptor Agonist Initiation With Concomitant Metformin Use: A Post Hoc Analysis of LEADER, STEP 2, SUSTAIN-6, and PIONEER 6

    Secondary analysis

All 4,758 Briefs in ExploreShowing Briefs 3,441–3,480 of 4,758, newest first